Adial Pharmaceuticals, Inc.
ADIL
$0.6655
-$0.0093-1.38%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.75M | 5.20M | 3.29M | 5.03M | 2.83M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 308.20K | 409.80K | 188.60K | 275.40K | 371.60K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | 4.40K | 346.80K | 36.00K | -- |
Total Current Assets | 4.06M | 5.62M | 3.82M | 5.34M | 3.20M |
|
|||||
Total Current Assets | 4.06M | 5.62M | 3.82M | 5.34M | 3.20M |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 3.30K | 3.50K | 3.60K | 3.80K | 3.90K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 5.04M | 6.71M | 4.95M | 6.68M | 4.74M |
|
|||||
Total Accounts Payable | 298.40K | 318.10K | 316.70K | 177.50K | 127.40K |
Total Accrued Expenses | 677.50K | 510.90K | 355.20K | 385.30K | 525.70K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 975.90K | 829.00K | 671.90K | 562.70K | 653.10K |
|
|||||
Total Current Liabilities | 975.90K | 829.00K | 671.90K | 562.70K | 653.10K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 975.90K | 829.00K | 671.90K | 562.70K | 653.10K |
|
|||||
Common Stock & APIC | 86.06M | 85.81M | 82.01M | 81.40M | 72.88M |
Retained Earnings | -82.00M | -79.92M | -77.73M | -75.27M | -68.80M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 4.07M | 5.88M | 4.28M | 6.12M | 4.08M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 4.07M | 5.88M | 4.28M | 6.12M | 4.08M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 4.07M | 5.88M | 4.28M | 6.12M | 4.08M |
|